Company intelligence / Profile preview
Pemix
- Ownership
- Private
- Development stage
- Other
Overview
Pemix is an Argentinian pharmaceutical company that specializes in the development, manufacturing, and distribution of high-complexity pharmaceutical products. The company focuses on therapeutic areas such as oncology, hematology, HIV, and rare diseases, providing a portfolio of specialty drugs and generic alternatives. Pemix operates primarily in the Latin American market, aiming to improve access to critical treatments through its regional distribution network and manufacturing capabilities. Its business model combines the commercialization of its own products with the representation of international pharmaceutical brands in the region.
- Therapeutic areas
- HematologyImmunologyNeurologyInfectious DiseasesRare DiseasesOncology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Pemix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pemix.